Cost-of-illness analyses for policy making: A cautionary tale of use and misuse
In summary, we recognize that many current COI analyses suffer from both data and methodological shortcomings. However, we believe that a carefully conducted COI study that clearly documents all assumptions and limitations can minimize many of the concerns we have noted and provide valuable information. We caution against the misuse of COI estimates and wish to remind readers that efforts to equate costs to savings are misguided and that COI estimates should be only one of the many factors that decision-makers require to properly allocate resources. As additional data sets become available and researchers continue toward adoption of a common framework for conducting COI analyses, COI estimates will continue to improve and cross-study comparisons will be less problematic.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- Health Policy & Services
- 3801 Applied economics
- 3214 Pharmacology and pharmaceutical sciences
- 1402 Applied Economics
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- Health Policy & Services
- 3801 Applied economics
- 3214 Pharmacology and pharmaceutical sciences
- 1402 Applied Economics
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences